![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
W Xu, XC Qiu and JS Han
Department of Physiology, Beijing Medical University, P.R. China.
The aim of the present study was to clarify the subtypes of serotonin (5-HT) receptors involved in spinal antinociception in the rat. 1) Intrathecal (i.t.) injection of 5-HT (25-200 micrograms) produced a dose-dependent increase in tail-flick latency. 2) Intrathecal injection of fluoxetine, a 5-HT uptake blocker (25-40 micrograms), resulted in a bell-shaped dose-related antinociception with peak effects occurring at 10 micrograms. 3) A bell-shaped antinociceptive effect was obtained by i.t. injection of the 5-HT1A agonist (+)-hydroxy-2-(di-N- propylamino)tetralin (0.25-2 micrograms), with the maximal effect occurring at 0.5 micrograms, which can be prevented by the 5-HT1A antagonist spiperone (25 micrograms i.t.). 4) A similar dose-response curve was obtained following the i.t. injection of the 5-HT1B agonist 1- [3-(trifluoromethyl)phenyl]-piperazine maleate (1-125 micrograms) with the maximal effect observed at 25 micrograms. 5) Neither the 5-HT2 agonist (+/-)-alpha-methyl-5-HT-maleate nor the 5-HT3 agonist (+/-)-2- methyl-5-HT-maleate produced significant antinociceptive effects at doses up to 50 micrograms. Spontaneous tail-flicks emerged at doses higher than 50 micrograms. 6) The antinociceptive effect induced by 5- HT (200 micrograms i.t.) could be attenuated dose-dependently either by the 5-HT1A antagonist spiperone (5 and 25 micrograms i.t.) or by the 5- HT1C/2 antagonist mianserin (0.5-50 micrograms i.t.), but not by the 5- HT2 antagonist 1-(1-naphthyl)piperazine hydrochloride or the 5-HT3 antagonist 3-tropanyl-indole-3-carboxylate.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  H. A. Mowafi, S. A. Arab, S. A. Ismail, and A. Al-Ghamdi The Effects of Intravenous Granisetron on the Sensory and Motor Blockade Produced by Intrathecal Bupivacaine Anesth. Analg., April 1, 2008; 106(4): 1322 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Brumley, I. D. Hentall, A. Pinzon, B. H. Kadam, A. Blythe, F. J. Sanchez, A. M. Taberner, and B. R. Noga Serotonin Concentrations in the Lumbosacral Spinal Cord of the Adult Rat Following Microinjection or Dorsal Surface Application J Neurophysiol, September 1, 2007; 98(3): 1440 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-Y. Liu, G.-G. Xing, X.-X. Qu, I. S. Xu, J.-S. Han, and Y. Wan Roles of 5-Hydroxytryptamine (5-HT) Receptor Subtypes in the Inhibitory Effects of 5-HT on C-Fiber Responses of Spinal Wide Dynamic Range Neurons in Rats J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1046 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sasaki, H. Obata, S. Saito, and F. Goto Antinociception with Intrathecal {alpha}-Methyl-5-Hydroxytryptamine, a 5-Hydroxytryptamine2A/2C Receptor Agonist, in Two Rat Models of Sustained Pain Anesth. Analg., April 1, 2003; 96(4): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Paul, D. Yao, P. Zhu, L. D. Minor, and M. M. Garcia 5-Hydroxytryptamine3 (5-HT3) Receptors Mediate Spinal 5-HT Antinociception: An Antisense Approach J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 674 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ito, E. Kumamoto, M. Takeda, M. Takeda, K. Shibata, H. Sagai, and M. Yoshimura Mechanisms for Ovariectomy-Induced Hyperalgesia and Its Relief by Calcitonin: Participation of 5-HT1A-Like Receptor on C-Afferent Terminals in Substantia Gelatinosa of the Rat Spinal Cord J. Neurosci., August 15, 2000; 20(16): 6302 - 6308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Hain, J. K. Belknap, and J. S. Mogil Pharmacogenetic Evidence for the Involvement of 5-Hydroxytryptamine (Serotonin)-1B Receptors in the Mediation of Morphine Antinociceptive Sensitivity J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 444 - 449. [Abstract] [Full Text]
|
|
|
|
|
|
Q.-Q. Sun and N. Dale Serotonergic Inhibition of the T-Type and High Voltage-Activated Ca2+ Currents in the Primary Sensory Neurons of Xenopus Larvae J. Neurosci., September 15, 1997; 17(18): 6839 - 6849. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
